Position in LLY
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$1,095,377,139
+$280,678,905 QoQ
Shares Held
913,248
+3.1% QoQ
Ownership
0.097%
of shares outstanding
% of Portfolio
2.94%
of 13F equity value
Holder Rank
#79
of 4,632 holders
Holding Since
Mar 2020
21 quarters on record
Voting authority
Sole 96%
Shared 0%
None 4%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Bank Julius Baer & Co. Ltd, Zurich holds $2,957,881,806 across 11 Drug Manufacturers - General names. LLY ranks #1 (37.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
913,248 | $1,095,377,139 | |
| 2 | JNJ |
Johnson & Johnson
|
2,722,956 | $691,549,135 | |
| 3 | MRK |
Merck & Co., Inc.
|
3,729,950 | $479,298,575 | |
| 4 | AZN |
Astrazeneca PLC
|
1,949,007 | $369,570,707 | |
| 5 | ABBV |
AbbVie Inc.
|
455,927 | $114,729,470 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
849,164 | $107,283,379 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
1,212,991 | $69,892,541 | |
| 8 | PFE |
Pfizer Inc
|
909,736 | $21,906,442 |
All Filings in LLY
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,095,377,139 | 913,248 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $814,698,234 | 885,763 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $803,957,436 | 748,090 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $604,971,255 | 792,885 | Shares | Sole | 2025-11-13 | |
| 2024-12-31 | $575,264,292 | 745,161 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $568,767,278 | 641,993 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $621,269,039 | 686,197 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $560,386,370 | 720,328 | Shares | Sole | 2024-05-14 | |
| 2023-09-30 | $265,591,448 | 494,464 | Shares | Sole | 2023-11-13 | |
| 2023-03-31 | $1,227,039 | 3,573 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $1,641,889 | 4,488 | Shares | Sole | 2023-01-24 | |
| 2022-09-30 | $1,667,839 | 5,158 | Shares | Sole | 2022-11-04 | |
| 2022-06-30 | $774,261 | 2,388 | Shares | Sole | 2022-07-22 | |
| 2022-03-31 | $896,051 | 3,129 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $55,244 | 200 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $46,210 | 200 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $45,904 | 200 | Shares | Sole | 2021-07-23 | |
| 2021-03-31 | $37,364 | 200 | Shares | Sole | 2021-05-10 | |
| 2020-09-30 | $483,729 | 3,268 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $381,882 | 2,326 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $2,006,307 | 14,463 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||